Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoffer Lind

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2022
In silico identification of a β<sub>2</sub>-adrenoceptor allosteric site that selectively augments canonical β<sub>2</sub>AR-Gs signaling and functionSushrut D Shah, Christoffer Lind, Francesco De Pascali, et al.
Molecular Pharmacology|June 22, 2023
Discovery and In Vitro Characterization of BAY 2686013, an Allosteric Small Molecule Antagonist of the Human Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorGernot Langer, John Scott, Christoffer Lind, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2022
In silico identification of a β<sub>2</sub>-adrenoceptor allosteric site that selectively augments canonical β<sub>2</sub>AR-Gs signaling and functionSushrut D Shah, Christoffer Lind, Francesco De Pascali, et al.
Molecular Pharmacology|June 22, 2023
Discovery and In Vitro Characterization of BAY 2686013, an Allosteric Small Molecule Antagonist of the Human Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorGernot Langer, John Scott, Christoffer Lind, et al.
Pageof 2